Skip to content

You are here: Home / People / Núria Porta Bleda

Núria Porta Bleda

Senior Medical Statistician
Clinical Trials and Statistics Unit (
ICR-CTSU) Institute of Cancer Research (London)


Research Areas:

Survival analysis: competing and semicompeting risks
Design and analysis of clinical trials
Modelling of complex diseases and predictive models



PhD in Statistics, Universitat Politècnica de Catalunya, July 2010.
MSc in Statistics, Universitat Politècnica de Catalunya, June 2004
MSc in Mathematics, Universitat Politècnica de Catalunya, June 2002

Current Projects:

  • 'Métodos avanzados en estudios de seguimiento: diseño de ensayos clínicos, datos longitudinales y censura en un intervalo' (MTM2012-38067-C02-01). Funded by: Ministerio de economía y competitividad. Participants:  Universitat Politècnica de Catalunya, Universidad de Vic. PI: Guadalupe Gómez Melis. Duration: January 2013-December 2015.
  • Member of "Red Nacional de Bioetadistica - Nodo Catalunya -Bio". Financed by “Ministerio de Innovación y Ciencia (MTM2010-09213-E)”. National and International participant Institutions. Investigator in charge: Carmen María Cadarso Suárez. Period: From 2010 - 2011.

Selection of Publications:

  • Lincker H, Ziogas C, Carr M, Porta N, Eichler HG (2014). Regulatory watch: Where do new medicines originate from in the EU?  Nature Reviews Drug Discovery 13, 92–93.
  • Coelho S, Ortíz F, Gelpi R, Koskinen P, Porta N, Bestard O, Melilli E, Taco O, Torras J, Honkanen E, Grinyó JM, Cruzado JM (2014). Sterile Leukocyturia is Associated with Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies. American Journal of Transplantation, Early view 12 Feb 2014.
  • Pedrós C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM (2014) Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol 70(3):361-7
  • Franco P, Porta N, Holliday JD, Willett P (2014). The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation. Journal of Cheminformatics 6:5
  • Muñoz L, Moure R, Porta N, González L, Guerra R, Alcaide F and Santin M. (2013) GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low burden countries? Diagnostic Microbiology and Infectious Disease, 75, p. 325–326
  • Fernández-Lorente L, Riera L, Bestard O, Carrera M, Gomà M, Porta N, Torras J, Melilli E, Gil-Vernet S, Grinyó JM, Cruzado JM (2012) Long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients. American Journal of Transplantation, 12(10), p.2781-8.
  • Porta N, Calle ML, Malats N and Gómez G (2012) A dynamic model for the risk of bladder cancer progression. Statistics in Medicine, 31,287-300.
  • Porta N, Bonet C, Cobo, E (2007). Discordance between reported intention-to-treat and per protocol analyses. Journal of clinical epidemiology, 60 (7): 663 – 669.


Institute of Cancer Research (ICR)

Clinical Trials and Statistics Unit (ICR-CTSU)

15 Cotswold Road,

Sutton, Surrey, SM2 5NG

Phone +44 208 722 4149

Fax +44 208 770 7876